TOLMAR Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • TOLMAR's estimated annual revenue is currently $209.2M per year.(i)
  • TOLMAR's estimated revenue per employee is $201,000

Employee Data

  • TOLMAR has 1041 Employees.(i)
  • TOLMAR grew their employee count by 4% last year.

TOLMAR's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP ManufacturingReveal Email/Phone
3
SVP DevelopmentReveal Email/Phone
4
VP Quality OperationsReveal Email/Phone
5
VP Regulatory AffairsReveal Email/Phone
6
SVP, General Manager – Men’s HealthReveal Email/Phone
7
VP Clinical DevelopmentReveal Email/Phone
8
VP Human ResourcesReveal Email/Phone
9
VP, Engineering/Maintenance/Facilities/Validation/EHSReveal Email/Phone
10
VP AccountingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$10.3M516%N/AN/A
#3
$4.4M22-8%N/AN/A
#4
$195M1220%$121.4MN/A
#5
$4.8M24-20%N/AN/A
#6
$6.8M34-19%N/AN/A
#7
$4.8M240%N/AN/A
#8
$4M40-11%$138MN/A
#9
$4.8M24-14%N/AN/A
#10
$69.5M346-6%N/AN/A
Add Company

What Is TOLMAR?

TOLMAR is a northern Colorado based pharmaceutical research, development, manufacturing and commercial operations company. TOLMAR develops and manufacturers both proprietary and generic pharmaceutical products with specific focus in therapeutic areas of dental, dermatology, and oncology products.

keywords:N/A

N/A

Total Funding

1041

Number of Employees

$209.2M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TOLMAR News

2022-04-20 - Marking and Pre-Suit Damages: What Happens when a ...

Tolmar argued that a predecessor owner of the patents had not complied with the marking statute, and since the patents had expired before...

2022-04-20 - Enanton (Leucorin Acetate) Market Size 2022-2030| Key ...

Tolmar; Teva; Sandoz (novartis); Scianda Pharma; Daewoong; Nanox; Gp Pharm; Enteris Biopharma; Xbrane Biopharma; Camurus; Chong Kun Dang...

2022-04-17 - Actinic Keratosis Drugs Market Size, Scope And Forecast ...

... GALDERMA, LEO Pharma, Valeant, Biofrontera, Novartis, Perrigo, Promius Pharma, Taro Pharmaceutical Industries, TOLMAR Pharmaceuticals.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$463.5M1319-4%N/A
#2
$300M18016%N/A
#3
$300M18733%N/A
#4
$734.3M29146%N/A
#5
N/A33946%N/A